Abstract
Background: We have previously shown that HCC patients and healthy subjects are equally responsive to a RNAdjuvant((R)), a novel TLR-7/8/RIG-I agonist......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
